Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Carboplatin, Docetaxel and Laboratory-Treated T Cells in Treating Patients With Refractory or Relapsed EBV-Positive Nasopharyngeal Cancer
Phase: Phase II
Type: Treatment
Age: 10 and over
Trial IDs: H-25145, NCI-2013-01143, CADEN, NCT00953420
Immune Therapy in Treating Patients with Epstein-Barr Virus Lymphoproliferative Disorders or Epstein-Barr Virus-Associated Malignancies
Phase: Phase II
Type: Diagnostic, Treatment
Age: any age
Trial IDs: 11-130, NCI-2012-00594, NCT01498484
Epstein-Barr Virus-Specific Cytotoxic T Lymphocytes in Treating Patients Undergoing Donor Bone Marrow Transplant
Phase: Phase I
Type: Treatment
Age: Not specified
Trial IDs: ETNA, NCI-2012-00655, NCT00608309, NCT00058812
Start Over